Unknown

Dataset Information

0

Role of PKR and Type I IFNs in viral control during primary and secondary infection.


ABSTRACT: Type I interferons (IFNs) are known to mediate viral control, and also promote survival and expansion of virus-specific CD8+ T cells. However, it is unclear whether signaling cascades involved in eliciting these diverse cellular effects are also distinct. One of the best-characterized anti-viral signaling mechanisms of Type I IFNs is mediated by the IFN-inducible dsRNA activated protein kinase, PKR. Here, we have investigated the role of PKR and Type I IFNs in regulating viral clearance and CD8+ T cell response during primary and secondary viral infections. Our studies demonstrate differential requirement for PKR, in viral control versus elicitation of CD8+ T cell responses during primary infection of mice with lymphocytic choriomeningitis virus (LCMV). PKR-deficient mice mounted potent CD8+ T cell responses, but failed to effectively control LCMV. The compromised LCMV control in the absence of PKR was multifactorial, and linked to less effective CD8+ T cell-mediated viral suppression, enhanced viral replication in cells, and lower steady state expression levels of IFN-responsive genes. Moreover, we show that despite normal expansion of memory CD8+ T cells and differentiation into effectors during a secondary response, effective clearance of LCMV but not vaccinia virus required PKR activity in infected cells. In the absence of Type I IFN signaling, secondary effector CD8+ T cells were ineffective in controlling both LCMV and vaccinia virus replication in vivo. These findings provide insight into cellular pathways of Type I IFN actions, and highlight the under-appreciated importance of innate immune mechanisms of viral control during secondary infections, despite the accelerated responses of memory CD8+ T cells. Additionally, the results presented here have furthered our understanding of the immune correlates of anti-viral protective immunity, which have implications in the rational design of vaccines.

SUBMITTER: Nakayama Y 

PROVIDER: S-EPMC2891951 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3014203 | biostudies-literature
| S-EPMC7953738 | biostudies-literature
| S-EPMC3874665 | biostudies-literature
| S-EPMC9613502 | biostudies-literature
| S-EPMC5679450 | biostudies-literature
| S-EPMC7162271 | biostudies-literature
2021-04-15 | PXD019093 | Pride
| S-EPMC4655130 | biostudies-literature
| S-EPMC10760173 | biostudies-literature
| S-EPMC4019976 | biostudies-literature